{"id":"NCT00724932","sponsor":"Merck Sharp & Dohme LLC","briefTitle":"Comparison of Sugammadex With Neostigmine During Laparoscopic Cholecystectomy or Appendectomy (P05699)","officialTitle":"A Multi-center, Randomized, Parallel-group, Comparative, Active-controlled, Safety-assessor Blinded Trial in Adult Subjects Comparing the Efficacy and Safety of Sugammadex (SCH 900616, ORG 25969) Administered at 1-2 PTC With Neostigmine Administered at Reappearance of T2 in Subjects Undergoing Laparoscopic Cholecystectomy or Appendectomy Under Propofol Anesthesia","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-07-16","primaryCompletion":"2009-04-01","completion":"2009-05-03","firstPosted":"2008-07-30","resultsPosted":"2013-04-29","lastUpdate":"2017-05-16"},"enrollment":140,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Anesthesia, General"],"interventions":[{"type":"DRUG","name":"Rocuronium","otherNames":["rocuronium bromide","Esmeron®"]},{"type":"DRUG","name":"Sugammadex","otherNames":["Org 25969","SCH 900616","MK-8616","Bridion®"]},{"type":"DRUG","name":"Neostigmine","otherNames":["Prostigmin®"]},{"type":"DRUG","name":"Atropine","otherNames":["atropine sulfate"]}],"arms":[{"label":"Sugammadex","type":"EXPERIMENTAL"},{"label":"Neostigmine","type":"EXPERIMENTAL"}],"summary":"The current trial was designed to demonstrate faster recovery from a neuromuscular blockade (NMB) induced by rocuronium after reversal at 1-2 Post Tetanic Count (PTC) by 4.0 mg.kg-1 sugammadex compared to 50 µg.kg-1 neostigmine at reappearance of second twitch (T2) in participants undergoing laparoscopic cholecystectomy or appendectomy under propofol anesthesia, to compare safety and to evaluate operating room and Post Anesthetic Care Unit (PACU) length of stay.","primaryOutcome":{"measure":"Time From Start of Administration of Investigational Medicinal Product (IMP, Sugammadex or Neostigmine) to Recovery of the Fourth Twitch/First Twitch (T4/T1) Ratio to 0.9","timeFrame":"From start of IMP administration to recovery of T4/T1 ratio to 0.9 (ranging from ~2 minutes to ~9 minutes)","effectByArm":[{"arm":"Sugammadex","deltaMin":2.4,"sd":null},{"arm":"Neostigmine","deltaMin":8.4,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":11},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["1952007","7762847","9040088","11883387","10485781","5534693","22698066"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":5,"n":66},"commonTop":["Procedural pain","Nausea","Vomiting","C-reactive protein increased","Anaesthetic complication cardiac"]}}